S3 Investment Company, Inc., a holding company with two subsidiaries doing business in the China market, announced that subsidiary SINO UJE, Ltd. has appointed a product manager for the Stomocur brand colostomy products of new supplier For Life GmbH.

SINO UJE was recently awarded exclusive distribution rights in China to the Stomocur two-piece system colostomy system, which has already received State Food and Drug Administration (SFDA) approval and is permitted to be sold on the Chinese market. SINO UJE is undertaking a comprehensive marketing program to expand awareness and grow sales for the Stomocur product line in the China market.

Founded in 1990, For Life’s product lines have been growing in popularity both in Germany and around the world.

About For Life of Berlin

Headquartered in Berlin, Germany, For Life has been developing and producing high-quality stoma products since 1990. The company has recently expanded its capacity through the addition of the latest technology in a specially constructed new factory. With this, and with the help of its motivated staff and management, For Life is able to satisfy the increasingly diverse requirements of a growing customer base.

About S3 Investment Company

S3 Investment Company, Inc. is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital, which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE, a non-stocking distributor of medical and industrial high-tech products to markets throughout China.

Source:佚名